Trials / Completed
CompletedNCT03368937
A Pilot Test of t:Slim X2 With Control-IQ Technology
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas - A Pilot Test of t:Slim X2 With Control-IQ Technology
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- University of Virginia · Academic / Other
- Sex
- All
- Age
- 18 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
A 36-48 hour admission testing the t:slim X2 with Control-IQ Technology
Detailed description
The objective of the study is for clinical staff to gain experience using the proposed artificial pancreas system named t:slim X2 with Control-IQ Technology and assess usability in a supervised setting prior to initiating home use in a Training protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tandem t:slim X2 with Control-IQ Technology | Subjects will wear the Tandem t:slim X2 with Control-IQ Technology during a 36-48 hour hotel admission. |
Timeline
- Start date
- 2017-12-08
- Primary completion
- 2017-12-11
- Completion
- 2017-12-11
- First posted
- 2017-12-11
- Last updated
- 2022-05-25
- Results posted
- 2019-02-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03368937. Inclusion in this directory is not an endorsement.